Great biochemical and clinical improvement has been observed in patients suffering from primary biliary cirrhosis after obeticholic acid was given to them as per the results of a new report Obeticholic acid at both a 10 mg dose and a 5 mg dose titrated to 10 mg, met the trial's primary composite endpoint of achieving a serum alkaline phosphatase (ALP) activity of less than 1.67 times the upper limit of normal (ULN), a total bilirubin within normal limits, and at ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment